Quest Partners LLC Beam Therapeutics Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Quest Partners LLC holds 4,953 shares of BEAM stock, worth $147,648. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,953Holding current value
$147,648% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
242Shares Held
65.5MCall Options Held
311KPut Options Held
777K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.18MShares$244 Million1.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.58MShares$226 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.71MShares$200 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.51MShares$134 Million0.7% of portfolio
-
Morgan Stanley New York, NY4.12MShares$123 Million0.01% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.1B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...